All Updates

All Updates

icon
Filter
Funding
BiomeSense raises USD 3 million in oversubscribed funding round
Precision Medicine
May 18, 2023
This week:
M&A
N-able acquires Adlumin for USD 266 million to strengthen cybersecurity offerings
Next-gen Cybersecurity
Today
M&A
Bitsight acquires Cybersixgill for USD 115 million to enhance threat intelligence capabilities
Cyber Insurance
Today
M&A
Snowflake acquires Datavolo to enhance data integration capabilities for undisclosed sum
Generative AI Infrastructure
Today
M&A
Snowflake acquires Datavolo to enhance data integration capabilities for undisclosed sum
Data Infrastructure & Analytics
Today
M&A
Almanac acquires Gro Intelligence's IP assets for undisclosed sum
Smart Farming
Yesterday
Partnerships
Aduro Clean Technologies partners with Zeton to build hydrochemolytic pilot plant
Waste Recovery & Management Tech
Yesterday
Funding
Oishii raises USD 16 million in Series B funding from Resilience Reserve
Vertical Farming
Yesterday
Management news
GrowUp Farms appoints Mike Hedges as CEO
Vertical Farming
Yesterday
M&A
Rise Up acquires Yunoo and expands LMS monetization capabilities
EdTech: Corporate Learning
Yesterday
Product updates
Uber releases five new features for holiday travel season
Travel Tech
Yesterday
Precision Medicine

Precision Medicine

May 18, 2023

BiomeSense raises USD 3 million in oversubscribed funding round

Funding

  • BiomeSense, a bioinformatics company focusing on the microbiome, has raised USD 3 million in an oversubscribed funding round led by Bluestein Ventures, with participation from Harvest Ridge Capital, SOSV, and Seerave Foundation. 

  • The funds will be used for the development of BiomeSense's "smart bathroom" technology, Gut Lab, and the expansion of its bioinformatics platform, Metabiome, with a commercial launch expected within the year.

  • BiomeSense is developing tools to unlock the potential of the microbiome in precision medicine. Its "smart bathroom" technology and bioinformatics platform enable the generation and analysis of large-scale microbiome datasets. The company claims that its GutLab automated laboratory system and MetaBiome bioinformatics platform are the first-ever solutions to provide continuous, at-home tracking and analysis of the microbiome. BiomeSense aims to partner with biopharma companies, probiotic companies, contract research organizations, and microbiome researchers. 

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.